Skip to main content
SpringerLink
Log in

Senken Antidementiva das Infarktrisiko?

Alzheimer-Demenz und Herz-Kreislauf-Erkrankungen

  • journal club
  • Published:
InFo Neurologie & Psychiatrie Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

1

Literatur

  • Nordström P, Religa D, Wimo A et al. The use of cholinesterase inhibitors and the risk of myocardial infarction and death: a nationwide cohort study in subjects with Alzheimer‘s disease. Eur Heart J 2013; Jun 4

Download references

Author information

Authors and Affiliations

  1. Allersberger Straße 89, 90461, Nürnberg, Deutschland

    Markus Weih (Facharzt für Neurologie, Psychiatrie und Psychotherapie, Nervenärztliche Gemeinschaftspraxis)

Authors
  1. Markus Weih
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Markus Weih.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Weih, M. Senken Antidementiva das Infarktrisiko?. InFo Neurologie 15, 20–21 (2013). https://doi.org/10.1007/s15005-013-0335-8

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s15005-013-0335-8

Search

Navigation